Easy Assessment of Osteoporosis in Older Patients
According to the National Osteoporosis Foundation (NOF), about 54 million Americans suffer from osteoporosis, presenting low bone mass, and suffering from brittle-bone related injuries, such as fractures, and broken bones. In fact, according to the NOF, the disease is responsible for “two million broken bones and $19 billion in related costs every year”, while by the year 2025, “experts predict that osteoporosis will be responsible for approximately three million fractures and $25.3 billion in costs annually.”
Sadly, most patients are not aware of having the condition before suffering from a broken bone or coming to realize they are losing inches off their height or backs starting to hunch. As the disease is most prevalent in older patients, early detection is crucial for the development of a thorough treatment plan and the adoption of lifestyle changes by patients.
Assessing and diagnosing older patients presents several challenges, particularly regarding patient mobility, and the risk of causing further damage to what might already be a weakened bone structure, through the current means of testing for osteoporosis.
Beammed Bone Scanners
With patented axial transmission technology, it bases their Omnipath™ and Sunlight Omnisense™ bone scanners, on ultrasonic speed waves providing a precise measurement due to the waves propagating along the bone’s maximal strength axis.
What’s more, through utilizing the axially transmitted speed of sound (SOS) as an indicator of overall bone strength, helps reflect properties such as mineral density, elasticity, cortical thickness, and microstructure. BeamMed Sunlight Omnisense™ device range is currently the lone product in its category that allows for multi-site assessments.
Thus, BeamMed’s Omnipath™ devices make for a groundbreaking means of assessing osteoporosis in older patients, owing to their portability, practicality, and tremendous ease of use, which helps test patients who cannot be tested in certain skeletal sites; uncover site-restricted osteoporosis, and monitor treatment results, easier and faster than ever before.
To learn more about BeamMed bone density assessment and monitoring solutions, please call 810-769-6808.Leave a reply